Search Within

Gregory J Riely

  1. "Glenn Heller"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (4)
Groups
  1. Biostatistics Service (14)
  2. Department of Medicine (14)
  3. Epidemiology and Biostatistics (14)
  4. Solid Tumor Oncology Division (14)
  5. Thoracic Oncology (14)
  6. GSK Faculty (13)

More Groups

People
  1. Glenn Heller (14)
  2. Mark Kris (11)
  3. Helena Yu (9)
  4. Marc Ladanyi (9)
  5. Charles Rudin (8)
  6. Maria Arcila (8)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Clinical Cancer Research (3)
  3. Journal of Thoracic Oncology (2)
  4. Annals of Oncology (1)
  5. British Journal of Cancer (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Association for Cancer Research (3)
  3. Elsevier Inc. (2)
  4. American Medical Association (1)
  5. Elsevier BV (1)
  6. Nature Publishing Group (1)

More Publishers

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases
    Journal Article

    Wilcox, J. A.; Jeng, M. Y.; Tischfield, S.; Sui, J. S. Y.; Nemirovsky, D.; Heller, G.; Choudhury, N. J.; Ross, J. S.; Rudin, C. M.; Riely, G. J.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Lorlatinib tolerability and association with clinical outcomes in patients with advanced ALK- or ROS1-rearranged NSCLC: A brief report
    Journal Article

    Thummalapalli, R.; Choudhury, N. J.; Ehrich, F.; Beardslee, T.; Brazel, D.; Zhang, S. S.; Merchant, S.; Chen, M. F.; Heller, G.; Ramalingam, S. S.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Journal Article

    Choudhury, N. J.; Marra, A.; Sui, J. S. Y.; Flynn, J.; Yang, S. R.; Falcon, C. J.; Selenica, P.; Schoenfeld, A. J.; Rekhtman, N.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Meeting Abstract

    Choudhury, N. J.; Marra, A.; Yang, S. R.; Falcon, C. J.; Heller, G.; Kris, M. G.; Reis-Filho, J. S.; Riely, G. J.; Yu, H. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions
    Journal Article

    Choudhury, N. J.; Schoenfeld, A. J.; Flynn, J.; Falcon, C. J.; Rizvi, H.; Rudin, C. M.; Kris, M. G.; Arcila, M. E.; Heller, G.; Yu, H. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer
    Journal Article

    Schoenfeld, A.; Bandlamudi, C.; Lavery, J. A.; Montecalvo, J.; Namakydoust, A.; Rizvi, H.; Egger, J.; Concepcion, C. P.; Paul, S.; Arcila, M. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save